PBS293-MMAE

N/A

Report date: 2026/05/12 20:00:17

First In Class

Base Information

Drug NamePBS293-MMAE

Drug Alias NamePBS293-MMAEPBS-293PBS293

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payload

Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1Anti-Ephrin type-A receptor 2

TargetsEpidermal growth factor receptor erbB1Ephrin type-A receptor 2

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPromatix Biosciences Ltd

China Registration ClassN/A

Develop Information

Active CompaniesPromatix Biosciences Ltd

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A